Study: hydroxychloroquine can boost COVID-19 survival chances by nearly 200%
OAN Newsroom
UPDATED 6:45 PM PT – Tuesday, June 8, 2021
Another study has confirmed hydroxychloroquine to be effective in the
treatment of COVID-19. Conducted by the Saint Barnabas Medical Center,
the research has found the combination of hydroxychloroquine and
antibiotic Zithromax effectively suppresses COVID-19.
The study
has suggested this treatment can increase survival chances by nearly
200 percent if given at high doses in mechanically ventilated patients
with severe COVID-19 illness. Scientists also reported that higher doses
of hydroxychloroquine led to a quicker recovery in 87-percent of
observed patients.
This comes after public health experts, including Dr. Anthony Fauci,
have denied the effectiveness of hydroxychloroquine in treating
COVID-19. Biological weapons expert, Dr. Steven Hatfill, has pointed
blame at these experts for the hundreds of thousands of American deaths
that resulted from the pandemic.
“It was false,” he asserted. “They didn’t want competition for the vaccines.”
The study also found hydroxychloroquine is particularly efficient in
terminally ill patients who would otherwise have died without that drug.
